LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1202 | 5013 | 0.2398 | -0.0296 |
MDA-MB-231 | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1817 | 5013 | 0.3625 | 0.1366 |
MDA-MB-231 | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4300 | 5013 | 0.8578 | 0.8073 |
MDA-MB-231 | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 5047 | 5013 | 1.0067 | 1.0090 |
MDA-MB-231 | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1100 | 5013 | 0.2194 | -0.0572 |
MDA-MB-231 | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 3476 | 5013 | 0.6935 | 0.5848 |
MDA-MB-231 | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4638 | 5013 | 0.9252 | 0.8987 |
MDA-MB-231 | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 2529 | 5013 | 0.5046 | 0.3290 |
MDA-MB-231 | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4959 | 5013 | 0.9892 | 0.9854 |
MDA-MB-231 | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4742 | 5013 | 0.9458 | 0.9267 |
MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1311 | 865 | 5013 | 0.1727 | -0.1205 |
MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1311 | 746 | 5013 | 0.1488 | -0.1528 |
MDA-MB-231 | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4082 | 5013 | 0.8142 | 0.7484 |
MDA-MB-231 | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 3674 | 5013 | 0.7328 | 0.6381 |
MDA-MB-231 | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 4618 | 5013 | 0.9212 | 0.8933 |
MDA-MB-231 | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 4618 | 5013 | 0.9212 | 0.8932 |
MDA-MB-231 | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 3739 | 5013 | 0.7459 | 0.6559 |
MDA-MB-231 | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 2071 | 5013 | 0.4132 | 0.2052 |
MDA-MB-231 | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1462 | 5013 | 0.2917 | 0.0407 |
MDA-MB-231 | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 1311 | 2426 | 5013 | 0.4839 | 0.3010 |
MDA-MB-231 | PD0325901 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 1494 | 5013 | 0.2980 | 0.0492 |
MDA-MB-231 | PD0325901 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 1276 | 5013 | 0.2545 | -0.0096 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 1311 | 5152 | 5013 | 1.0278 | 1.0376 |
MDA-MB-231 | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 1311 | 2896 | 5013 | 0.5778 | 0.4282 |
MDA-MB-231 | Pelitinib | 3.33 | uM | LJP5 | 72 | hr | 1311 | 2847 | 5013 | 0.5679 | 0.4148 |